Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Infect Drug Resist ; 16: 3893-3901, 2023.
Article in English | MEDLINE | ID: mdl-37361935

ABSTRACT

Background: Pneumonia infected by Chlamydia abortus (C. abortus) is rare, especially complicated with severe acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS). Case Presentation: We presented the clinical details of a 44-year-old male who was diagnosed with C. abortus pneumonia, which rapidly progressed and ultimately led to ARDS, sepsis and MODS. Although he was initially diagnosed with pneumonia upon admission, no pathogenic bacteria were detected in sputum by conventional tests. Empirical intravenous infusion of meropenem and moxifloxacin was administered, but unfortunately, his condition deteriorated rapidly, especially respiratory status. On Day 2 after extracorporeal membrane oxygenation (ECMO) initiation, metagenomic next-generation sequencing (mNGS) was performed on the patient's bronchoalveolar lavage fluid, which indicated an infection with C. abortus. The patient's antimicrobial therapy was adjusted to oral doxycycline (0.1g every 12h), intravenous azithromycin (0.5g every day), and imipenem and cilastatin sodium (1g every 6h). The patient's condition improved clinically and biologically. However, the patient was discharged due to financial reasons and unfortunately passed away eight hours later. Conclusion: Infections with C. abortus can result in severe ARDS and serious visceral complications which necessitate prompt diagnosis and active intervention by clinicians. The case highlights the significance of mNGS as an essential diagnostic tool for uncommon pathogens. Tetracyclines, macrolides or their combinations are effective choices for treatment of C. abortus pneumonia. Further study is needed to explore the transmission routes of C. abortus pneumonia and establish precise guidelines for antibiotic treatment.

2.
Materials (Basel) ; 15(9)2022 Apr 29.
Article in English | MEDLINE | ID: mdl-35591540

ABSTRACT

In this paper, the corrosion resistance of FeCoSiBPC amorphous alloy after pre-oxidation and non-oxidation heat treatment is investigated. The corrosion behaviors of Fe80Co3Si3B10P1C3 amorphous alloys in 1 mol/L NaCl solution were investigated by the electrochemical workstation. The pre-oxidation heat treatment can improve the corrosion resistance of FeCoSiBPC amorphous alloy through an increase in the Ecorr value from -0.736 to -0.668 V, which makes it easy to reach a passive state. The corroded morphology and products of amorphous alloys were tested by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The SEM/TEM analysis showed that, after pre-oxidation treatment, the oxide layer was divided into two layers: the inner layer was amorphous, the outer layer appeared crystalline, and the main oxide was Fe2O3. During the oxidation process, Co and P elements diffused from the inner layer to the outer layer, forming phosphorus and cobalt oxides with high corrosion resistance on the surface of the ribbon, thereby improving the corrosion resistance of the ribbon.

3.
Biomed Res Int ; 2019: 6414673, 2019.
Article in English | MEDLINE | ID: mdl-31360719

ABSTRACT

OBJECTIVE: This meta-analysis with trial sequential analysis (TSA) compared the clinical efficacy of extracorporeal cardiopulmonary resuscitation (ECPR) with conventional CPR (CCPR) for adult patients who experienced in-hospital cardiac arrest (IHCA) or out-of-hospital CA (OHCA). METHODS: A literature search was used to identify eligible publications (up to 30 July 2018) from PubMed, the Cochrane Library, the ISI Web of Knowledge, and Embase. Two investigators independently conducted the literature search, study selection, data extraction, and quality evaluation. Meta-analysis and TSA were used to analyze each outcome, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was used to evaluate the level of evidence. The primary outcome was 30-day survival, and the secondary outcomes were 30-day neurologic outcome, 3-6 months' survival, 3-6 months' neurological outcome, 1-year survival, and 1-year neurological outcome. RESULTS: We identified 13 eligible observational studies for the final analysis. Pooled analyses showed that ECPR was associated with a significantly better 30-day survival (RR = 1.60, 95% CI = 1.25-2.06) and 30-day neurologic outcome (RR = 2.69, 95% CI = 1.63-4.46), and TSA confirmed these results. However, subgroup analysis of patients with OHCA indicated that ECPR and CCPR had similar effects on 30-day survival (RR = 1.18, 95% CI = 0.71-1.97), which was not confirmed by TSA. Analysis of OHCA patients indicated that ECPR provided a better 30-day neurological outcome (RR = 3.93, 95% CI = 1.00-15.50), but TSA did not support these results. Analysis of IHCA patients indicated that ECPR was associated with a better 30-day survival (RR 1.90, 95% CI 1.43-2.52) and 30-day neurologic outcome (RR 2.02, 95% CI 1.21-3.39), and TSA supported these results. Other subgroup analyses showed that the results were generally consistent, regardless of nation, propensity score matching, presumed etiology, whether the CA was witnessed or not, and study quality. CONCLUSIONS: Relative to CCPR, ECPR improved the survival and neurological outcome of patients who had IHCA. Compared to IHCA patients, TSA could not confirm better survival and neurologic outcome of ECPR in OHCA patients, suggesting that further studies are needed. TRIAL REGISTRATION: This trial was registered with PROSPERO (CRD42018100513) on 17 July 2018.


Subject(s)
Cardiopulmonary Resuscitation/methods , Heart Arrest/therapy , Out-of-Hospital Cardiac Arrest/therapy , Aged , Extracorporeal Membrane Oxygenation , Female , Heart Arrest/mortality , Heart Arrest/physiopathology , Humans , Male , Middle Aged , Observational Studies as Topic , Out-of-Hospital Cardiac Arrest/mortality , Out-of-Hospital Cardiac Arrest/physiopathology , Time Factors , Treatment Outcome
4.
Medicine (Baltimore) ; 97(22): e10946, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29851838

ABSTRACT

RATIONALE: We report a man with amyopathic dermatomyositis (ADM) complicated by severe interstitial lung disease (ILD) received extracorporeal membrane oxygenation (ECMO) in combination with double filtration plasmapheresis (DFPP). This is the first report of the utility of ECMO in combination with DFPP in ADM related ILD in adults. PATIENT CONCERNS: A 48-year-old man who was previously healthy had a 2-month history of cough and shortness of breath, which aggravated in 5 days. DIAGNOSES: Amyopathic dermatomyositis and complicated by severe interstitial lung disease. INTERVENTIONS: ECMO was giving when the patient suffered acute respiratory failure. Though corticosteroids was giving, primary disease was still developing with relapses of spontaneous pneumomediastinum and pneumothorax. Then, DFPP treatment was initiated. OUTCOME: After the treatments above, the patient's clinical condition improved with the reduction of bilateral interstitial infiltrates and improvement of lung compliance. Unfortunately, he discontinued the treatment because of the financial problem. LESSONS: When get a rapid progressive interstitial lung disease for no apparent reason, amyopathic dermatomyositis should be considered, especially with suspected skin lesions. ECMO, in combination with DFPP, should be considered as a supportive therapy and initiated early in patients in acute respiratory failure secondary to ADM-ILD. Prompt initiation of DFPP in dermatomyositis patients with ILD might help reduce the occurrence of spontaneous pneumomediastinum or pneumothorax.


Subject(s)
Dermatomyositis/complications , Extracorporeal Membrane Oxygenation/methods , Lung Diseases, Interstitial/therapy , Plasmapheresis/methods , Combined Modality Therapy , Dermatomyositis/therapy , Glucocorticoids/therapeutic use , Humans , Lung Diseases, Interstitial/etiology , Male , Mediastinal Emphysema/etiology , Mediastinal Emphysema/therapy , Middle Aged , Pneumothorax/etiology , Pneumothorax/therapy
5.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue ; 29(12): 1140-1143, 2017 Dec.
Article in Chinese | MEDLINE | ID: mdl-29216952

ABSTRACT

OBJECTIVE: Sepsis-induced cardiomyopathy is a reversible myocardial dysfunction due to sepsis, which may be severe enough to complicate cardiogenic shock, and without effective drug and with high mortality during the acute phase. A case of sepsis-induced cardiomyopathy complicated with cardiogenic shock was treated in the intensive care unit (ICU) of Shunde Hospital Southern Medical University. A 37 years old female patient was admitted because she had suffered repeated fever for 5 days, chest tightness and abdominal pain for 3 days. At the same time, there were severe cardiac depression and abdominal infection, which could be explained by the monismtheory of sepsis cardiomyopathy.The cardiogenic shock patient was not improved after antibiotic therapy and hemodynamic support, extracorporeal membrane oxygenation (ECMO) support was prescribed. The circulation failure was smoothly got through with ECMO and was transfer from ICU to ordinary ward. Computed tomographic angiography (CTA) of abdominal aorta and colonoscopy indicated lesions of small intestine. The diagnosis of infection and bleeding in ileum diverticulum was confirmed during the operation and the lesions was removed. She recovered and was discharged 1 week after operation. Through the case review, we aim to improve the awareness of sepsis-induced cardiomyopathy and the value of ECMO support in cardiogenic shock.


Subject(s)
Cardiomyopathies , Adult , Extracorporeal Membrane Oxygenation , Female , Hemodynamics , Humans , Sepsis , Shock, Cardiogenic , Treatment Outcome
6.
Small ; 13(48)2017 12.
Article in English | MEDLINE | ID: mdl-29125682

ABSTRACT

TiO2 nanosheets have continuously been intriguing due to their high surface activities as photocatalyst but still challenging to synthesis large-scale 2D nanostructures. A special microstructure evolution of TiO2 , ripening in aqueous solution at low temperature (≈4 °C), is found for the first time, i.e., from the initial aperiodic atom-networks gradually into low crystallized continuous spongy structure with small crystal facets and ultimately forming large-size anatase nanosheets with exposed (101) and (200) facets. Based on this finding, the synthesized anatase TiO2 nanosheets possess monodispersed large-scale 2D nanostructure so as to exhibit appreciable quantum size effects and remarkable enhanced optical absorption capacity. Using photocatalytic reduction of Cr (VI) to Cr (III) as the probe reaction to evaluate photocatalytic activities of the TiO2 nanosheets, the reductivity of Cr (VI) achieves 99.8% in 15 min under irradiation of 200-800 nm light. At the same time, an in situ Cr (III)-doping occurs spontaneously and triggers pronounced visible light driven photocatalysis, reducing 99% of Cr (VI) in 100 min under irradiation of 400-800 nm light.

SELECTION OF CITATIONS
SEARCH DETAIL
...